EKOS PE ACCEL Trademark

Trademark Overview


On Monday, December 12, 2016, a trademark application was filed for EKOS PE ACCEL with the United States Patent and Trademark Office. The USPTO has given the EKOS PE ACCEL trademark a serial number of 87265335. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 15, 2021. This trademark is owned by EKOS Corporation. The EKOS PE ACCEL trademark is filed in the Medical Instrument Products and Education & Entertainment Services categories with the following description:

Education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; training in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related trea...

Surgical apparatus and instruments; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; Drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; Drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the ...
ekos pe accel

General Information


Serial Number87265335
Word MarkEKOS PE ACCEL
Filing DateMonday, December 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements


Goods and ServicesEducation services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; training in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and distribution of course material in connection therewith; providing computer, electronic and on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; advisory services in the fields of medical education; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; electronic on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine
Goods and ServicesSurgical apparatus and instruments; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; Drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; Drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the circulatory system; Medical apparatus and instruments for use in the prevention and treatment of the circulatory system issues and conditions, vascular issues and conditions, and intracranial haemorrhages, cerebral haemorrhages, and hematoma; medical devices which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; catheters; parts and fittings for all the aforesaid goods
Disclaimer with Predetermined Text"PE"

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateThursday, December 15, 2016
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEKOS Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Party NameEKOS Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98011

Trademark Events


Event DateEvent Description
Monday, March 15, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Sunday, August 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, August 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, August 30, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, August 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, August 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, August 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 11, 2020EXTENSION 5 GRANTED
Thursday, July 23, 2020EXTENSION 5 FILED
Tuesday, August 11, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 23, 2020TEAS EXTENSION RECEIVED
Saturday, February 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2020EXTENSION 4 GRANTED
Thursday, February 6, 2020EXTENSION 4 FILED
Thursday, February 6, 2020TEAS EXTENSION RECEIVED
Wednesday, July 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2019EXTENSION 3 GRANTED
Monday, July 29, 2019EXTENSION 3 FILED
Monday, July 29, 2019TEAS EXTENSION RECEIVED
Thursday, October 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 23, 2018EXTENSION 2 GRANTED
Tuesday, October 23, 2018EXTENSION 2 FILED
Tuesday, October 23, 2018TEAS EXTENSION RECEIVED
Friday, August 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2018EXTENSION 1 GRANTED
Wednesday, August 1, 2018EXTENSION 1 FILED
Wednesday, August 1, 2018TEAS EXTENSION RECEIVED
Tuesday, February 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 9, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, November 9, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, November 9, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, October 6, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 6, 2017LETTER OF SUSPENSION E-MAILED
Friday, October 6, 2017SUSPENSION LETTER WRITTEN
Saturday, September 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 15, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 15, 2017NON-FINAL ACTION WRITTEN
Tuesday, March 14, 2017ASSIGNED TO EXAMINER
Wednesday, February 1, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, January 31, 2017ASSIGNED TO LIE
Thursday, January 12, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 15, 2016NEW APPLICATION ENTERED IN TRAM